Related content

Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma

By Niioka Takenori   Uno Tsukasa   Yasui-Furukori Norio   Takahata Takenori   Shimizu Mikiko   Sugawara Kazunobu   Tateishi Tomonori  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 575-580

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics

By Motoshima Kohei   Nakamura Yoichi   Sano Kazumi   Ikegami Yoji   Ikeda Takaya   Mizoguchi Kosuke   Takemoto Shinnosuke   Fukuda Minoru   Nagashima Seiji   Iida Tetsuya   Tsukamoto Kazuhiro   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1299-1304

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite

ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma

By Giacalone Nicholas J   Den Robert B   Eisenberg Rosana   Chen Heidi   Olson Sandra J   Massion Pierre P   Carbone David P   Lu Bo  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 737-745

Future Medicine

Access to resources Recommend Favorite

Death Receptor 5 and Bcl-2 Protein Expression as Predictors of Tumor Response to Gemcitabine and Cisplatin in Patients with Advanced Non-Small-Cell Lung Cancer

By Han Ji-Youn   Hong Eun Kyung   Choi Byung Gil   Park Jin No   Kim Ki Won   Kang Jin Hyung   Jin Jong-Youl   Park Suk Young   Hong Young Seon   Lee Kyung Shik  

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 355-362

Humana Press, Inc

Access to resources Recommend Favorite